IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients

Purpose: Dysmetabolism and high circulating insulin-like growth factor 1 (IGF-1) would increase breast cancer risk, but its association with survival in HER2+ breast cancer patients has not been well-studied. Herein, we aim to evaluate the prognostic value of IGF-1 and metabolic abnormalities in HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yiwei, Wu, Jiayi, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193870/
https://www.ncbi.nlm.nih.gov/pubmed/32391265
http://dx.doi.org/10.3389/fonc.2020.00550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193870/
https://www.ncbi.nlm.nih.gov/pubmed/32391265
http://dx.doi.org/10.3389/fonc.2020.00550

Ejemplares similares